|
1
|
Pascale RM, Calvisi DF, Simile MM, Feo CF
and Feo F: The Warburg effect 97 years after its discovery. Cancers
(Basel). 12:28192020.
|
|
2
|
Pillai SR, Damaghi M, Marunaka Y, Spugnini
EP, Fais S and Gillies RJ: Causes, consequences, and therapy of
tumors acidosis. Cancer Metastasis Rev. 38:205–222. 2019.
|
|
3
|
Faubert B, Li KY, Cai L, Hensley CT, Kim
J, Zacharias LG, Yang C, Do QN, Doucette S, Burguete D, et al:
Lactate metabolism in human lung tumors. Cell. 171:358–371.e9.
2017.
|
|
4
|
Kennedy KM, Scarbrough PM, Ribeiro A,
Richardson R, Yuan H, Sonveaux P, Landon CD, Chi JT, Pizzo S,
Schroeder T and Dewhirst MW: Catabolism of exogenous lactate
reveals it as a legitimate metabolic substrate in breast cancer.
PLoS One. 8:e751542013.
|
|
5
|
Damaghi M, West J, Robertson-Tessi M, Xu
L, Ferrall-Fairbanks MC, Stewart PA, Persi E, Fridley BL, Altrock
PM, Gatenby RA, et al: The harsh microenvironment in early breast
cancer selects for a Warburg phenotype. Proc Natl Acad Sci USA.
118:e20113421182021.
|
|
6
|
Brizel DM, Schroeder T, Scher RL, Walenta
S, Clough RW, Dewhirst MW and Mueller-Klieser W: Elevated tumor
lactate concentrations predict for an increased risk of metastases
in head-and-neck cancer. Int J Radiat Oncol Biol Phys. 51:349–353.
2001.
|
|
7
|
Walenta S, Wetterling M, Lehrke M,
Schwickert G, Sundfør K, Rofstad EK and Mueller-Klieser W: High
lactate levels predict likelihood of metastases, tumor recurrence,
and restricted patient survival in human cervical cancers. Cancer
Res. 60:916–921. 2000.
|
|
8
|
Lora-Michiels M, Yu D, Sanders L, Poulson
JM, Azuma C, Case B, Vujaskovic Z, Thrall DE, Charles HC and
Dewhirst MW: Extracellular pH and P-31 magnetic resonance
spectroscopic variables are related to outcome in canine soft
tissue sarcomas treated with thermoradiotherapy. Clin Cancer Res.
12:5733–5740. 2006.
|
|
9
|
Meyer KA, Kammerling EM, et al: pH studies
of malignant tissues in human beings. Cancer Res. 8:513–518.
1948.
|
|
10
|
Persi E, Duran-Frigola M, Damaghi M, Roush
WR, Aloy P, Cleveland JL, Gillies RJ and Ruppin E: Systems analysis
of intracellular pH vulnerabilities for cancer therapy. Nat Commun.
9:29972018.
|
|
11
|
Vlachostergios PJ, Oikonomou KG, Gibilaro
E and Apergis G: Elevated lactic acid is a negative prognostic
factor in metastatic lung cancer. Cancer Biomark. 15:725–734.
2015.
|
|
12
|
Schoonjans CA, Joudiou N, Brusa D, Corbet
C, Feron O and Gallez B: Acidosis-induced metabolic reprogramming
in tumor cells enhances the anti-proliferative activity of the PDK
inhibitor dichloroacetate. Cancer Lett. 470:18–28. 2020.
|
|
13
|
Ning WR, Jiang D, Liu XC, Huang YF, Peng
ZP, Jiang ZZ, Kang T, Zhuang SM, Wu Y and Zheng L: Carbonic
anhydrase XII mediates the survival and prometastatic functions of
macrophages in human hepatocellular carcinoma. J Clin Invest.
132:e1531102022.
|
|
14
|
Desquiret-Dumas V, Leman G, Wetterwald C,
Chupin S, Lebert A, Khiati S, Le Mao M, Geffroy G, Kane MS,
Chevrollier A, et al: Warburg-like effect is a hallmark of complex
I assembly defects. Biochim Biophys Acta Mol Basis Dis.
1865:2475–2489. 2019.
|
|
15
|
Boedtkjer E and Pedersen SF: The acidic
tumor microenvironment as a driver of cancer. Annu Rev Physiol.
82:103–126. 2020.
|
|
16
|
Moellering RE, Black KC, Krishnamurty C,
Baggett BK, Stafford P, Rain M, Gatenby RA and Gillies RJ: Acid
treatment of melanoma cells selects for invasive phenotypes. Clin
Exp Metastasis. 25:411–425. 2008.
|
|
17
|
Damaghi M, Tafreshi NK, Lloyd MC, Sprung
R, Estrella V, Wojtkowiak JW, Morse DL, Koomen JM, Bui MM, Gatenby
RA and Gillies RJ: Chronic acidosis in the tumour microenvironment
selects for overexpression of LAMP2 in the plasma membrane. Nat
Commun. 6:87522015.
|
|
18
|
Ibrahim-Hashim A and Estrella V: Acidosis
and cancer: From mechanism to neutralization. Cancer Metastasis
Rev. 38:149–155. 2019.
|
|
19
|
Harguindey S, Alfarouk K, Polo Orozco J,
Fais S and Devesa J: Towards an integral therapeutic protocol for
breast cancer based upon the new H+-centered anticancer
paradigm of the late post-Warburg era. Int J Mol Sci.
21:74752020.
|
|
20
|
de la Cruz-López KG, Castro-Muñoz LJ,
Reyes-Hernández DO, García-Carrancá A and Manzo-Merino J: Lactate
in the regulation of tumor microenvironment and therapeutic
approaches. Front Oncol. 9:11432019.
|
|
21
|
Massagué J and Obenauf AC: Metastatic
colonization by circulating tumour cells. Nature. 529:298–306.
2016.
|
|
22
|
Amintas S, Bedel A, Moreau-Gaudry F,
Boutin J, Buscail L, Merlio JP, Vendrely V, Dabernat S and Buscail
E: Circulating tumor cell clusters: United we stand divided we
fall. Int J Mol Sci. 21:26532020.
|
|
23
|
Chrabaszcz K, Jasztal A, Smęda M,
Zieliński B, Blat A, Diem M, Chlopicki S, Malek K and Marzec KM:
Label-free FTIR spectroscopy detects and visualizes the early stage
of pulmonary micrometastasis seeded from breast carcinoma. Biochim
Biophys Acta Mol Basis Dis. 1864:3574–3584. 2018.
|
|
24
|
Gómez-Cuadrado L, Tracey N, Ma R, Qian B
and Brunton VG: Mouse models of metastasis: Progress and prospects.
Dis Model Mech. 10:1061–1074. 2017.
|
|
25
|
Estrella V, Chen T, Lloyd M, Wojtkowiak J,
Cornnell HH, Ibrahim-Hashim A, Bailey K, Balagurunathan Y, Rothberg
JM, Sloane BF, et al: Acidity generated by the tumor
microenvironment drives local invasion. Cancer Res. 73:1524–1535.
2013.
|
|
26
|
Chen WJ, Ho CC, Chang YL, Chen HY, Lin CA,
Ling TY, Yu SL, Yuan SS, Chen YJ, Lin CY, et al: Cancer-associated
fibroblasts regulate the plasticity of lung cancer stemness via
paracrine signalling. Nat Commun. 5:34722014.
|
|
27
|
Peppicelli S, Bianchini F, Torre E and
Calorini L: Contribution of acidic melanoma cells undergoing
epithelial-to-mesenchymal transition to aggressiveness of
non-acidic melanoma cells. Clin Exp Metastasis. 31:423–433.
2014.
|
|
28
|
Chen S, Zhou Y, Chen Y and Gu J: Fastp: An
ultra-fast all-in-one FASTQ preprocessor. Bioinformatics.
34:i884–i890. 2018.
|
|
29
|
Liao Y, Smyth GK and Shi W: FeatureCounts:
An efficient general purpose program for assigning sequence reads
to genomic features. Bioinformatics. 30:923–930. 2014.
|
|
30
|
Love MI, Huber W and Anders S: Moderated
estimation of fold change and dispersion for RNA-seq data with
DESeq2. Genome Biol. 15:5502014.
|
|
31
|
Robinson MD, McCarthy DJ and Smyth GK:
edgeR: A bioconductor package for differential expression analysis
of digital gene expression data. Bioinformatics. 26:139–140.
2010.
|
|
32
|
Bu D, Luo H, Huo P, Wang Z, Zhang S, He Z,
Wu Y, Zhao L, Liu J, Guo J, et al: KOBAS-i: Intelligent
prioritization and exploratory visualization of biological
functions for gene enrichment analysis. Nucleic Acids Res. 49(W1):
W317–W325. 2021.
|
|
33
|
Ruzzolini J, Peppicelli S, Andreucci E,
Bianchini F, Margheri F, Laurenzana A, Fibbi G, Pimpinelli N and
Calorini L: Everolimus selectively targets vemurafenib resistant
BRAFV600E melanoma cells adapted to low pH. Cancer Lett.
408:43–54. 2017.
|
|
34
|
Su T, Huang S, Zhang Y, Guo Y, Zhang S,
Guan J, Meng M, Liu L, Wang C, Yu D, et al: miR-7/TGF-β2 axis
sustains acidic tumor microenvironment-induced lung cancer
metastasis. Acta Pharm Sin B. 12:821–837. 2022.
|
|
35
|
Andreucci E, Peppicelli S, Ruzzolini J,
Bianchini F, Biagioni A, Papucci L, Magnelli L, Mazzanti B, Stecca
B and Calorini L: The acidic tumor microenvironment drives a
stem-like phenotype in melanoma cells. J Mol Med (Berl).
98:1431–1446. 2020.
|
|
36
|
Choodetwattana P, Proungvitaya S,
Jearanaikoon P and Limpaiboon T: The upregulation of OCT4 in acidic
extracellular pH is associated with gemcitabine resistance in
cholangiocarcinoma cell lines. Asian Pac J Cancer Prev.
20:2745–2748. 2019.
|
|
37
|
Murlidhar V, Reddy RM, Fouladdel S, Zhao
L, Ishikawa MK, Grabauskiene S, Zhang Z, Lin J, Chang AC, Carrott
P, et al: Poor prognosis indicated by venous circulating tumor cell
clusters in early-stage lung cancers. Cancer Res. 77:5194–5206.
2017.
|
|
38
|
Edgar R, Domrachev M and Lash AE: Gene
expression omnibus: NCBI gene expression and hybridization array
data repository. Nucleic Acids Res. 30:207–210. 2002.
|
|
39
|
Hynes RO: Integrins: Bidirectional,
allosteric signaling machines. Cell. 110:673–687. 2002.
|
|
40
|
Cardones AR, Murakami T and Hwang ST:
CXCR4 enhances adhesion of B16 tumor cells to endothelial cells in
vitro and in vivo via beta(1) integrin. Cancer Res. 63:6751–6757.
2003.
|
|
41
|
Wagenblast E, Soto M, Gutiérrez-Ángel S,
Hartl CA, Gable AL, Maceli AR, Erard N, Williams AM, Kim SY,
Dickopf S, et al: A model of breast cancer heterogeneity reveals
vascular mimicry as a driver of metastasis. Nature. 520:358–362.
2015.
|
|
42
|
Young SA, McCabe KE, Bartakova A, Delaney
J, Pizzo DP, Newbury RO, Varner JA, Schlaepfer DD and Stupack DG:
Integrin α4 enhances metastasis and may be associated with poor
prognosis in MYCN-low neuroblastoma. PLoS One. 10:e01208152015.
|
|
43
|
Bulian P, Shanafelt TD, Fegan C, Zucchetto
A, Cro L, Nückel H, Baldini L, Kurtova AV, Ferrajoli A, Burger JA,
et al: CD49d is the strongest flow cytometry-based predictor of
overall survival in chronic lymphocytic leukemia. J Clin Oncol.
32:897–904. 2014.
|
|
44
|
Pulkka OP, Mpindi JP, Tynninen O, Nilsson
B, Kallioniemi O, Sihto H and Joensuu H: Clinical relevance of
integrin alpha 4 in gastrointestinal stromal tumours. J Cell Mol
Med. 22:2220–2230. 2018.
|
|
45
|
Marusyk A, Tabassum DP, Altrock PM,
Almendro V, Michor F and Polyak K: Non-cell-autonomous driving of
tumour growth supports sub-clonal heterogeneity. Nature. 514:54–58.
2014.
|
|
46
|
Michl J, Wang Y, Monterisi S, Blaszczak W,
Beveridge R, Bridges EM, Koth J, Bodmer WF and Swietach P:
CRISPR-Cas9 screen identifies oxidative phosphorylation as
essential for cancer cell survival at low extracellular pH. Cell
Rep. 38:1104932022.
|
|
47
|
Anemone A, Consolino L, Conti L, Irrera P,
Hsu MY, Villano D, Dastrù W, Porporato PE, Cavallo F and Longo DL:
Tumour acidosis evaluated in vivo by MRI-CEST pH imaging reveals
breast cancer metastatic potential. Br J Cancer. 124:207–216.
2021.
|
|
48
|
Munoz R, Man S, Shaked Y, Lee CR, Wong J,
Francia G and Kerbel RS: Highly efficacious nontoxic preclinical
treatment for advanced metastatic breast cancer using combination
oral UFT-cyclophosphamide metronomic chemotherapy. Cancer Res.
66:3386–3391. 2006.
|
|
49
|
Minn AJ, Gupta GP, Siegel PM, Bos PD, Shu
W, Giri DD, Viale A, Olshen AB, Gerald WL and Massagué J: Genes
that mediate breast cancer metastasis to lung. Nature. 436:518–524.
2005.
|
|
50
|
Guy CT, Webster MA, Schaller M, Parsons
TJ, Cardiff RD and Muller WJ: Expression of the neu protooncogene
in the mammary epithelium of transgenic mice induces metastatic
disease. Proc Natl Acad Sci USA. 89:10578–10582. 1992.
|
|
51
|
Yu IF, Yu YH, Chen LY, Fan SK, Chou HYE
and Yang JT: A portable microfluidic device for the rapid diagnosis
of cancer metastatic potential which is programmable for
temperature and CO2. Lab Chip. 14:3621–3628. 2014.
|
|
52
|
Pang X, He X, Qiu Z, Zhang H, Xie R, Liu
Z, Gu Y, Zhao N, Xiang Q and Cui Y: Targeting integrin pathways:
Mechanisms and advances in therapy. Signal Transduct Target Ther.
8:12023.
|
|
53
|
Sabatier L, Chen D, Fagotto-Kaufmann C,
Hubmacher D, McKee MD, Annis DS, Mosher DF and Reinhardt DP:
Fibrillin assembly requires fibronectin. Mol Biol Cell. 20:846–858.
2009.
|
|
54
|
Qian F, Vaux DL and Weissman IL:
Expression of the integrin alpha 4 beta 1 on melanoma cells can
inhibit the invasive stage of metastasis formation. Cell.
77:335–347. 1994.
|
|
55
|
Schlesinger M and Bendas G: Contribution
of very late antigen-4 (VLA-4) integrin to cancer progression and
metastasis. Cancer Metastasis Rev. 34:575–591. 2015.
|
|
56
|
Xie J, Yang P, Lin HP, Li Y, Clementino M,
Fenske W, Yang C, Wang C and Wang Z: Integrin α4 up-regulation
activates the hedgehog pathway to promote arsenic and
benzo[α]pyrene co-exposure-induced cancer stem cell-like property
and tumorigenesis. Cancer Lett. 493:143–155. 2020.
|
|
57
|
Malfuson JV, Boutin L, Clay D, Thépenier
C, Desterke C, Torossian F, Guerton B, Anginot A, de Revel T,
Lataillade JJ and Le Bousse-Kerdilès MC: SP/drug efflux
functionality of hematopoietic progenitors is controlled by
mesenchymal niche through VLA-4/CD44 axis. Leukemia. 28:853–864.
2014.
|
|
58
|
Golebiewska A, Brons NHC, Bjerkvig R and
Niclou SP: Critical appraisal of the side population assay in stem
cell and cancer stem cell research. Cell Stem Cell. 8:136–147.
2011.
|
|
59
|
Wu C and Alman BA: Side population cells
in human cancers. Cancer Lett. 268:1–9. 2008.
|
|
60
|
Maniotis AJ, Folberg R, Hess A, Seftor EA,
Gardner LM, Pe'er J, Trent JM, Meltzer PS and Hendrix MJ: Vascular
channel formation by human melanoma cells in vivo and in vitro:
Vasculogenic mimicry. Am J Pathol. 155:739–752. 1999.
|
|
61
|
Upile T, Jerjes W, Radhi H, Al-Khawalde M,
Kafas P, Nouraei S and Sudhoff H: Vascular mimicry in cultured head
and neck tumour cell lines. Head Neck Oncol. 3:552011.
|
|
62
|
Fu R, Du W, Ding Z, Wang Y, Li Y, Zhu J,
Zeng Y, Zheng Y, Liu Z and Huang JA: HIF-1α promoted vasculogenic
mimicry formation in lung adenocarcinoma through NRP1 upregulation
in the hypoxic tumor microenvironment. Cell Death Dis.
12:3942021.
|
|
63
|
He X, You J, Ding H, Zhang Z, Cui L, Shen
X, Bian X, Liu Y and Chen J: Vasculogenic mimicry, a negative
indicator for progression free survival of lung adenocarcinoma
irrespective of first line treatment and epithelial growth factor
receptor mutation status. BMC Cancer. 21:1322021.
|
|
64
|
Williamson SC, Metcalf RL, Trapani F,
Mohan S, Antonello J, Abbott B, Leong HS, Chester CP, Simms N,
Polanski R, et al: Vasculogenic mimicry in small cell lung cancer.
Nat Commun. 7:133222016.
|
|
65
|
Baeten CIM, Hillen F, Pauwels P, de Bruine
AP and Baeten CGMI: Prognostic role of vasculogenic mimicry in
colorectal cancer. Dis Colon Rectum. 52:2028–2035. 2009.
|
|
66
|
Ruffini F, Graziani G, Levati L, Tentori
L, D'Atri S and Lacal PM: Cilengitide downmodulates invasiveness
and vasculogenic mimicry of neuropilin 1 expressing melanoma cells
through the inhibition of αvβ5 integrin. Int J Cancer.
136:E545–E558. 2015.
|
|
67
|
Vartanian A, Stepanova E, Grigorieva I,
Solomko E, Belkin V, Baryshnikov A and Lichinitser M: Melanoma
vasculogenic mimicry capillary-like structure formation depends on
integrin and calcium signaling. Microcirculation. 18:390–399.
2011.
|
